Senescence: a companion in chemotherapy?

被引：16

作者：

Berns, A

机构：

[1] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands

[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands

来源：

CANCER CELL | 2002年 / 1卷 / 04期

关键词：

D O I：

10.1016/S1535-6108(02)00063-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Mouse lymphoma model points to an unsuspected role of drug-induced "senescence.".

引用

页码：309 / 311

页数：3

共 15 条

[1]

Allen JD, 2000, CANCER RES, V60, P5761

[2]

Does resistance to apoptosis affect clinical response to antitumor drugs? [J].

Borst, P ;

Borst, J ;

Smets, LA .

DRUG RESISTANCE UPDATES, 2001, 4 (02) :129-131

[3]

Brown JM, 1999, CANCER RES, V59, P1391

[4]

Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].

Bunz, F ;

Hwang, PM ;

Torrance, C ;

Waldman, T ;

Zhang, YG ;

Dillehay, L ;

Williams, J ;

Lengauer, C ;

Kinzler, KW ;

Vogelstein, B .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269

[5]

Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].

Bunz, F ;

Dutriaux, A ;

Lengauer, C ;

Waldman, T ;

Zhou, S ;

Brown, JP ;

Sedivy, JM ;

Kinzler, KW ;

Vogelstein, B .

SCIENCE, 1998, 282 (5393) :1497-1501

[6]

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis [J].

Eischen, CM ;

Weber, JD ;

Roussel, MF ;

Sherr, CJ ;

Cleveland, JL .

GENES & DEVELOPMENT, 1999, 13 (20) :2658-2669

[7]

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice [J].

Krimpenfort, P ;

Quon, KC ;

Mooi, WJ ;

Loonstra, A ;

Berns, A .

NATURE, 2001, 413 (6851) :83-86

[8]

Differential effects of p19Arf and p16Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages [J].

Randle, DH ;

Zindy, F ;

Sherr, CJ ;

Roussel, MF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9654-9659

[9]

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53 [J].

Schmitt, CA ;

McCurrach, ME ;

de Stanchina, E ;

Wallace-Brodeur, RR ;

Lowe, SW .

GENES & DEVELOPMENT, 1999, 13 (20) :2670-2677

[10]

Apoptosis and chemoresistance in transgenic cancer models [J].

Schmitt, CA ;

Lowe, SW .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2002, 80 (03) :137-146

← 1 2 →